VN1R46P

Across TCGA pan-cancer cohorts, VN1R46P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated VN1R46P data layer.

The strongest signal is observed in sarcoma (SARC), where higher VN1R46P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated VN1R46P expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

SARC, LIHC, and SKCM are the cancer types where VN1R46P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SARC	OS	Tertile	All	0.599	0.867	.001	21	view →
LIHC	OS	Tertile	All	0.515	0.788	.029	9	view →
SKCM	OS	Tertile	All	1.000	0.333	.025	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

VN1R46P–SARC (OS)

Open the SARC breakdown →